Aquatic Capital Management LLC Biogen Inc. Transaction History

Aquatic Capital Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$212.02 - $267.71 $15.6 Million - $19.7 Million	73,700 Added 1083.82%	80,500 $17.4 Million
Q4 2023 Feb 14, 2024	BUY	$222.59 - $267.94 $1.32 Million - $1.59 Million	5,920 Added 672.73%	6,800 $1.76 Million
Q3 2023 Nov 14, 2023	SELL	$253.3 - $285.89 $1.9 Million - $2.15 Million	-7,520 Reduced 89.52%	880 $226,000
Q2 2023 Aug 14, 2023	BUY	$275.25 - $318.06 $2.31 Million - $2.67 Million	8,400 New	8,400 $2.39 Million
Q4 2022 Feb 14, 2023	BUY	$252.44 - $306.72 $8.76 Million - $10.6 Million	34,700 New	34,700 $9.61 Million
Q2 2022 Aug 15, 2022	BUY	$187.54 - $223.02 $843,930 - $1 Million	4,500 New	4,500 $918,000
Q1 2022 May 16, 2022	SELL	$193.77 - $244.14 $232,524 - $292,968	-1,200 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$223.92 - $287.77 $268,704 - $345,324	1,200 New	1,200 $288,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Aquatic Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aquatic Capital Management LLC with notifications on news.